Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Mainz Biomed N.V. - Ordinary Shares (NQ:MYNZ)

1.560 UNCHANGED
Streaming Delayed Price Updated: 3:58 PM EDT, Oct 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 1.560
Bid (Size) 1.560 (1)
Ask (Size) 1.600 (1)
Prev. Close 1.560
Today's Range 1.560 - 1.560
52wk Range 0.1800 - 8.200
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Mainz Biomed to Present the Future of Colorectal Cancer Screening at WEO CRC Screening Committee Meeting
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
Company Provides Update on eAArly DETECT 2 Study 
From Mainz BioMed NV
Via GlobeNewswire

Performance

YTD
-63.7%
-63.7%
1 Month
-7.7%
-7.7%
3 Month
+9.1%
+9.1%
6 Month
-54.7%
-54.7%
1 Year
+503.9%
+503.9%

More News

Read More
Mainz Biomed Announces Registration of ColoAlert in the United Kingdom
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Receives Swiss Regulatory Approval to Market ColoAlert®
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Pricing of $3.0 Million Follow-On Offering of Ordinary Shares and Warrants
From Mainz BioMed NV
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Mainz Biomed and CARE Conclude Cooperation Agreement for Joint Care Concept for Health Insurance Companies
From Mainz BioMed NV
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Mainz Biomed Half Year 2025 Update: Accelerating FDA Pathway for NextGen Colorectal Cancer Screening and Expansion with Pancreatic Cancer Screening Acquisition
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Secures Public Funding to Advance Innovative Pancreatic Cancer Screening Test
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Initiates Feasibility Study of Biomarker Panel in Pancreatic Cancer Project
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Announces Pricing of $4.0 Million Follow-On Offering of Ordinary Shares and Warrants
From Mainz BioMed NV
Via GlobeNewswire
These stocks are moving in today's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Novavax Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Mainz Biomed Announces Interim Read Out For Its eAArly DETECT 2 Clinical Study
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Enters into Technology Partnership with EDX Medical Group
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Provides First Quarter 2025 Corporate Update and Path to FDA Premarket Approval
From Mainz BioMed NV
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Mainz Biomed Reports 2024 Financial Results and Provides Corporate Update
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Enrolls First Patient in Its eAArly DETECT 2 Clinical Study
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet
Via Stocktwits
Colorectal Cancer Awareness Month: Mainz Biomed Advocates for a Shift from Screening to Prevention
From Mainz BioMed NV
Via GlobeNewswire
Mainz Biomed Expands into Switzerland with labor team w
From Mainz BioMed NV
Via GlobeNewswire

Frequently Asked Questions

Is Mainz Biomed N.V. - Ordinary Shares publicly traded?
Yes, Mainz Biomed N.V. - Ordinary Shares is publicly traded.
What exchange does Mainz Biomed N.V. - Ordinary Shares trade on?
Mainz Biomed N.V. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Mainz Biomed N.V. - Ordinary Shares?
The ticker symbol for Mainz Biomed N.V. - Ordinary Shares is MYNZ on the Nasdaq Stock Market
What is the current price of Mainz Biomed N.V. - Ordinary Shares?
The current price of Mainz Biomed N.V. - Ordinary Shares is 1.560
When was Mainz Biomed N.V. - Ordinary Shares last traded?
The last trade of Mainz Biomed N.V. - Ordinary Shares was at 10/01/25 03:58 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.